XML 22 R57.htm IDEA: XBRL DOCUMENT v2.4.0.6
Discontinued Operations The summary of the assets and liabilities related to Pharmaceutical Manufacturing- China discontinued operations (Details) (USD $)
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Pharmaceutical Manufacturing - China business [Member]
Dec. 31, 2011
Pharmaceutical Manufacturing - China business [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Cash and cash equivalents $ 16,149,188 $ 2,875,232 $ 16,149,200 $ 8,707,000
Restricted cash     1,115,300 0
Accounts receivable, net     7,317,000 5,525,700
Inventory     20,445,200 16,505,700
Deferred income taxes     350,700 463,700
Prepaid expenses and other current assets     1,461,400 777,500
Property, plant and equipment, net     36,097,200 36,490,400
Land use rights, net     4,856,200 4,872,400
Goodwill     0 8,495,700
Intangible assets, net     1,352,400 21,846,400
Other assets     2,757,800 2,459,900
Total assets     91,902,400 106,144,400
Accounts Payable     17,310,500 7,950,300
Accrued liabilities     1,887,700 1,705,800
Bank loans     14,238,000 15,712,000
Notes payable     2,230,600 0
Income tax payable     1,381,500 621,600
Deferred income taxes     5,913,700 6,177,400
Unearned revenue     1,216,900 1,315,400
Amount due related parties     21,254,900 20,862,700
Total Liabilities     $ 65,433,800 $ 54,345,200